XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Total Snowflake Inc. Stockholders’ Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Jan. 31, 2022     312,377,000          
Beginning balance at Jan. 31, 2022 $ 5,049,045 $ 5,049,045 $ 31 $ 0 $ 6,984,669 $ (16,286) $ (1,919,369) $ 0
Beginning balance, treasury stock (in shares) at Jan. 31, 2022       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     4,926,000          
Issuance of common stock upon exercise of stock options 30,933 30,933 $ 1   30,932      
Issuance of common stock under employee stock purchase plan (in shares)     286,000          
Issuance of common stock under employee stock purchase plan 40,931 40,931     40,931      
Issuance of common stock in connection with a business combination (in shares)     1,916,000          
Issuance of common stock in connection with a business combination 438,916 438,916     438,916      
Issuance of common stock in connection with a business combination subject to future vesting (in shares)     409,000          
Vesting of early exercised stock options 183 183     183      
Vesting of restricted stock units (in shares)     2,409,000          
Shares withheld related to net share settlement of equity awards (in shares)     (826,000)          
Shares withheld related to net share settlement of equity awards (138,641) (138,641)     (138,641)      
Stock-based compensation 631,839 631,839     631,839      
Capital contributions from noncontrolling interest holders 13,000             13,000
Other comprehensive income (loss) (52,893) (52,893)       (52,893)    
Net loss (590,042) (589,536)         (589,536) (506)
Ending balance (in shares) at Oct. 31, 2022     321,497,000          
Ending balance at Oct. 31, 2022 5,423,271 5,410,777 $ 32 $ 0 7,988,829 (69,179) (2,508,905) 12,494
Ending balance, treasury stock (in shares) at Oct. 31, 2022       0        
Beginning balance (in shares) at Jul. 31, 2022     319,897,000          
Beginning balance at Jul. 31, 2022 5,426,323 5,426,323 $ 32 $ 0 7,782,117 (47,857) (2,307,969) 0
Beginning balance, treasury stock (in shares) at Jul. 31, 2022       0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     984,000          
Issuance of common stock upon exercise of stock options 7,366 7,366     7,366      
Issuance of common stock under employee stock purchase plan (in shares)     102,000          
Issuance of common stock under employee stock purchase plan 14,837 14,837     14,837      
Issuance of common stock in connection with a business combination (in shares)     2,000          
Vesting of early exercised stock options 61 61     61      
Vesting of restricted stock units (in shares)     786,000          
Shares withheld related to net share settlement of equity awards (in shares)     (274,000)          
Shares withheld related to net share settlement of equity awards (52,507) (52,507)     (52,507)      
Stock-based compensation 236,955 236,955     236,955      
Capital contributions from noncontrolling interest holders 13,000             13,000
Other comprehensive income (loss) (21,322) (21,322)       (21,322)    
Net loss (201,442) (200,936)         (200,936) (506)
Ending balance (in shares) at Oct. 31, 2022     321,497,000          
Ending balance at Oct. 31, 2022 5,423,271 5,410,777 $ 32 $ 0 7,988,829 (69,179) (2,508,905) 12,494
Ending balance, treasury stock (in shares) at Oct. 31, 2022       0        
Beginning balance (in shares) at Jan. 31, 2023     323,305,000          
Beginning balance at Jan. 31, 2023 $ 5,468,615 5,456,436 $ 32 $ 0 8,210,750 (38,272) (2,716,074) 12,179
Beginning balance, treasury stock (in shares) at Jan. 31, 2023 0     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     5,951,000          
Issuance of common stock upon exercise of stock options $ 38,821 38,821 $ 1   38,820      
Issuance of common stock under employee stock purchase plan (in shares)     516,000          
Issuance of common stock under employee stock purchase plan 61,234 61,234     61,234      
Vesting of early exercised stock options 163 163     163      
Vesting of restricted stock units (in shares)     5,131,000          
Shares withheld related to net share settlement of equity awards (in shares)     (1,740,000)          
Shares withheld related to net share settlement of equity awards $ (279,067) (279,067)     (279,067)      
Repurchases of common stock (in shares) (500,000)     (500,000)        
Repurchases of common stock as treasury stock $ (68,299) (68,299)   $ (68,299)        
Repurchases and retirement of common stock (in shares)     (3,512,000)          
Repurchases and retirement of common stock (523,433) (523,433)         (523,433)  
Stock-based compensation 899,747 899,747     899,747      
Other comprehensive income (loss) 11,064 11,064       11,064    
Net loss (668,078) (666,745)         (666,745) (1,333)
Ending balance (in shares) at Oct. 31, 2023     329,651,000          
Ending balance at Oct. 31, 2023 $ 4,940,767 4,929,921 $ 33 $ (68,299) 8,931,647 (27,208) (3,906,252) 10,846
Ending balance, treasury stock (in shares) at Oct. 31, 2023 (500,000)     (500,000)        
Beginning balance (in shares) at Jul. 31, 2023     329,878,000          
Beginning balance at Jul. 31, 2023 $ 5,298,227 5,286,938 $ 33 $ (68,299) 8,679,411 (32,244) (3,291,963) 11,289
Beginning balance, treasury stock (in shares) at Jul. 31, 2023       (500,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 1,095,000   1,095,000          
Issuance of common stock upon exercise of stock options $ 7,294 7,294     7,294      
Issuance of common stock under employee stock purchase plan (in shares)     204,000          
Issuance of common stock under employee stock purchase plan 24,169 24,169     24,169      
Vesting of early exercised stock options 41 41     41      
Vesting of restricted stock units (in shares)     1,632,000          
Shares withheld related to net share settlement of equity awards (in shares)     (551,000)          
Shares withheld related to net share settlement of equity awards (90,162) (90,162)     (90,162)      
Repurchases and retirement of common stock (in shares)     (2,607,000)          
Repurchases and retirement of common stock (400,038) (400,038)         (400,038)  
Stock-based compensation 310,894 310,894     310,894      
Other comprehensive income (loss) 5,036 5,036       5,036    
Net loss (214,694) (214,251)         (214,251) (443)
Ending balance (in shares) at Oct. 31, 2023     329,651,000          
Ending balance at Oct. 31, 2023 $ 4,940,767 $ 4,929,921 $ 33 $ (68,299) $ 8,931,647 $ (27,208) $ (3,906,252) $ 10,846
Ending balance, treasury stock (in shares) at Oct. 31, 2023 (500,000)     (500,000)